Merck Life Science SRL
46.3 FTEMerck Life Science reported revenue of €158.5m for the 2025 financial year (non-consolidated annual accounts filed with the NBB on 19 Jun 2026), with 46.3 full-time equivalents.
By total assets for 2025, Merck Life Science ranks among the 50 largest of the 360 companies in its sector (NACE 4685) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Merck Life Science shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -8 % Equity -28 % Total assets -14 % Headcount (avg FTE) +7 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Merck Life Science's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Merck Life Science's financial analysis
- Solvency47.5%sector median: 49.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Merck Life Science
Merck Life Science's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0425.578.392
- VAT number
- BE0425578392
- Peppol
- Registered · 0208:0425578392 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Mar 1984
- Registered office
- 1560 Hoeilaart
- Size
- Small · 46.3 FTE
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Wholesale of chemical products for industrial use (NACE 46851)
Merck Life Science (SRL) has been based in Hoeilaart since 1984, active in: wholesale of chemical products for industrial use. For 2025, it reports revenue of €158.5m, a net profit of €4.85m and equity of €21.9m. With 46.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 47.5%, below the median of its sector (49.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Merck Life Science
Companies in the same business, of comparable size and area, outside its group.
- Novasol Wholesale of chemical products Kraainem · balance sheet €47.6m
- Proviron Functional Chemicals Manufacture of other organic basic chemicals Ostend · balance sheet €54.0m
- Ecochem International Manufacture of other chemical products n.e.c. Willebroek · balance sheet €30.2m
- Menarini Benelux Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €48.6m
- Benechim Manufacture of other organic basic chemicals Lessines · balance sheet €33.9m
- Michelman International Belgium Manufacture of other organic basic chemicals Aubange · balance sheet €24.2m
- Govi Production Company Manufacture of refined petroleum products and fossil fuel products Ghent · balance sheet €45.0m
- CTF 2000 Manufacture of other chemical products n.e.c. Zele · balance sheet €17.8m
Frequently asked questions about Merck Life Science
What is the revenue of Merck Life Science?
According to the 2025 annual accounts filed with the NBB, the revenue of Merck Life Science amounts to 158,479,314 €.
What is the VAT number of Merck Life Science?
In Belgium, the VAT number is the company number prefixed with BE: BE0425578392 for Merck Life Science, if the company is VAT-registered. Its company number (CBE) is 0425.578.392.
Where is the registered office of Merck Life Science?
According to the CBE register, the registered office of Merck Life Science is in 1560 Hoeilaart.
What is the equity of Merck Life Science?
At the close of the 2025 financial year, the equity of Merck Life Science amounts to 21,893,926 €, a solvency of 47.5% of total assets.
How many people work at Merck Life Science?
46.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Merck Life Science?
The register lists 2 active mandates at Merck Life Science. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Merck Life Science within its sector?
By total assets for 2025, Merck Life Science ranks among the 50 largest of the 360 companies in its sector (NACE 4685) in Belgium that filed accounts for that financial year.
The full file of Merck Life Science
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →